• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Quintiles

Analyst: CRM market “bad as it’s ever been” | Wall Street Beat

March 22, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

The cardiac rhythm management market is "about as bad as it has ever been," according to an analyst with Gabelli & Co., due in part to headwinds from a federal probe and a negative journal article.

Filed Under: News Well, Wall Street Beat Tagged With: 4G Biometrics, Abbott, ActiveCare, Applied Science Inc., AtriCure Inc., Baxter, becton dickinson, Boston Scientific, C.R. Bard, Cardiac Rhythm Management, CardioComm, Edwards Lifesciences, Fenwal Inc., GI Dynamics, Kensey Nash Corp., MELA Sciences Inc., MiMedx Group Inc., Myoscience, Olympus, Organovo, Quintiles, stjudemedical, Syneron Medical Ltd., Teleflex, Thermedical, Tobii Technology, Volcano Corp.

Vision-Sciences puts Cynthia Ansari in the corner office | Personnel Moves

August 12, 2011 By MassDevice staff Leave a Comment

Vision-Sciences

Endoscopic device maker Vision-Sciences Inc. (NSDQ:VSCI) announced that they had found someone to take over the corner office, naming Cynthia Ansari CEO.

Ansari steps will take over the top seat from interim CEO Warren Bielke, who has steered the company since his appointment in November, 2009, after previous CEO Ron Hadani resigned for personal reasons.

Filed Under: Endoscopic, News Well Tagged With: Alphatec, Haemonetics, Imaging Diagnostic Systems, Imalux Corp., Personnel Moves, Quintiles, Smith & Nephew, Varian Medical Systems, Vision-Sciences Inc.

Revolutions Medical taps new CFO | Personnel Moves

June 9, 2011 By MassDevice staff Leave a Comment

MassDevice.com Personnel Moves

Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.

Filed Under: News Well Tagged With: Cynosure Inc., Personnel Moves, Quintiles, Revolutions Medical Corp., UnitedHealth Group, Welch Allyn

Access Scientific scoops up $10 million | Funding Roundup

June 9, 2011 By MassDevice staff Leave a Comment

Funding

Access Scientific Inc., makers of the Picc Wand and Power Wand IV catheters, closed a $10 million equity financing round.

Investment was led by CAC, a private equity firm, and followed by Access Scientific’s previous investors.

The company’s IV catheters are designed reduce patient discomfort by allowing blood tests to be drawn and fluids and medications to be delivered through a single device, which can last the duration of an entire hospital stay.

Filed Under: Catheters, Health Information Technology, News Well Tagged With: Access Scientific Inc., Crux Biomedical, Endosphere, Quintiles, Revolutions Medical Corp., SBR Health Inc., SeptRx Inc., Teleflex, Venture Capital/Private Equity

INC Research buys Australian CRO Trident to boost global presence

June 5, 2011 By MassDevice Leave a Comment

INC Research

INC Research, still completing its $232 million acquisition of clinical research organization Kendle International Inc. (NSDQ:KNDL), bought yet another CRO to add to its global footprint.

Raleigh, N. C.-based INC Research acquired Australian CRO Trident Clinical Research in an aggressive move that gets INC into a fast-growing market for early phase clinical studies.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Covance Inc., INC Research Inc., Quintiles, Trident Clinical Research

Quintiles aims to restructure debt with $2 billion in credit | Funding roundup

May 13, 2011 By MedCity News

Funding

Quintiles is resuming its plans to raise more than $2 billion in bank financing.

The Durham, N.C.-based, contract research organization is planning to enter into a new $2.2 billion credit facility, with proceeds from the borrowed funding being used to refinance $1.7 billion in existing debt, including an offer to buy $525 million of 9.5 percent outstanding senior notes that are due in 2014.

Filed Under: News Well Tagged With: Advanced BioHealing Inc., Angiotech, Avedro Inc., CardioDx Inc., Cardiva Medical Inc., DaVita Inc., Lantheus Medical Imaging, Life Technologies Corp., MindChild Medical Inc., MoMelan Technologies, Quintiles, Seventh Sense Biosystems Inc., Sorin Group, Varian Medical Systems, Venture Capital/Private Equity, WaveMark Inc., WaveTec Vision

Quintiles tapped for global health initiative

March 26, 2011 By MedCity News Leave a Comment

company

Quintiles will bring its clinical trial services to a global consortium supported in part by the Bill & Melinda Gates Foundation aimed at bringing new, affordable medicines to the world’s poorest countries.

The Durham, N.C.-based company was selected as a preferred provider to 14 Product Development Partnerships, or PDPs — nonprofit entities that work to develop new drugs for underserved patient populations.

The PDP model is largely one of outsourced drug development, from R&D through clinical trials, according to the company.

Filed Under: News Well Tagged With: Bill & Melinda Gates Foundation, Clinical Trials, Quintiles

Quintiles spikes $2.4 billion financing move

March 24, 2011 By MedCity News Leave a Comment

Quintiles

Quintiles’ plans for $2.43 billion in bank financing have been put off indefinitely due to what the clinical research organization now describes as “recent unfavorable global credit market conditions.”

In postponing the financing, the Durham, N.C.-based CRO also said it would terminate its tender offer to pay cash to buy up to $525 million of 9.5 percent outstanding senior notes that are due in 2014.

Filed Under: News Well, Outsourcing, Research & Development Tagged With: Quintiles

Quintiles looks to drum up $2.43 billion

March 9, 2011 By MedCity News Leave a Comment

Quintiles logo

Quintiles plans to raise $2.43 billion that the conctract research organization will use to refinance existing debt and apply to future deals that could include acquisitions and new partnerships.

In securing the bank financing, the Durham, N.C.-based CRO is taking advantage of what it believes are favorable conditions in the financial markets, spokesman Phil Bridges said.

“It’s a good debt market; it’s favorable for us,” Bridges said.

Filed Under: News Well, Outsourcing Tagged With: Clinical Trials, Quintiles

Quintiles inks drug manufacturing deal with Samsung

February 26, 2011 By MedCity News Leave a Comment

Quintiles logo

Quintiles is partnering with Samsung Group on a $266 million initiative to bring the South Korean conglomerate into the drug manufacturing business.

Durham, N.C.-based Quintiles provides an array of services for pharmaceutical companes and is the largest contract research organization in the industry. Quintiles spokesman Phil Bridges said that the company’s involvement with Samsung is a $30 million stake in the effort.

Filed Under: News Well, Pharmaceutical, Research & Development Tagged With: Quintiles

Plexus wins FDA clearance for hemorrhoid-prevention device | Regulatory roundup

February 26, 2011 By MassDevice staff Leave a Comment

Clearances roundup

Here’s a roundup of companies announcing clearances and approvals from the Food & Drug Administration and foreign regulatory agencies. Check out MassDevice’s compilation of the latest regulatory news for additional clearances and approvals.

Filed Under: Electronic Medical Records (EMR), Health Information Technology, News Well Tagged With: Gift Bans, Plexus Biomedical Inc., Quintiles

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS